Literature DB >> 12014529

Apolipoprotein B metabolism: tracer kinetics, models, and metabolic studies.

John R Burnett1, P Hugh R Barrett.   

Abstract

The study of apolipoprotein (apo) B metabolism is central to our understanding of lipoprotein metabolism. However, the assembly and secretion of apoB-containing lipoproteins is a complex process. Specialized techniques, developed and applied to in vitro and in vivo studies of apoB metabolism, have provided insights into the mechanisms involved in the regulation of this process. Moreover, these studies have important implications for understanding both the pathophysiology as well as the therapeutic options for the dyslipidemias. The purpose of this review is to examine the role of apoB in lipoprotein metabolism and to explore the applications of kinetic analysis and multicompartmental modeling to the study of apoB metabolism. New developments and significant advances over the last decade are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014529     DOI: 10.1080/10408360208951113

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  10 in total

Review 1.  Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments.

Authors:  Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2006-09-01       Impact factor: 5.922

2.  Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease.

Authors:  F Magkos; E Fabbrini; K Korenblat; A L Okunade; B W Patterson; S Klein
Journal:  Int J Obes (Lond)       Date:  2010-12-21       Impact factor: 5.095

Review 3.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

4.  Common and rare gene variants affecting plasma LDL cholesterol.

Authors:  John R Burnett; Amanda J Hooper
Journal:  Clin Biochem Rev       Date:  2008-02

5.  Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.

Authors:  David B Rozema; David L Lewis; Darren H Wakefield; So C Wong; Jason J Klein; Paula L Roesch; Stephanie L Bertin; Tom W Reppen; Qili Chu; Andrei V Blokhin; James E Hagstrom; Jon A Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

6.  Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.

Authors:  Dick C Chan; P Hugh R Barrett; Gerald F Watts
Journal:  Clin Biochem Rev       Date:  2004-02

7.  Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo.

Authors:  Faidon Magkos; Bettina Mittendorfer
Journal:  Clin Lipidol       Date:  2009-04-01

8.  Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.

Authors:  Natalya S Petrova; Ivan V Chernikov; Mariya I Meschaninova; Iiya S Dovydenko; Aliya G Venyaminova; Marina A Zenkova; Valentin V Vlassov; Elena L Chernolovskaya
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

9.  Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet.

Authors:  Zhi-Hong Yang; Hiroko Miyahara; Jiro Takeo; Akimasa Hatanaka; Masashi Katayama
Journal:  Lipids Health Dis       Date:  2011-10-25       Impact factor: 3.876

10.  Metabolism of PLTP, CETP, and LCAT on multiple HDL sizes using the Orbitrap Fusion Lumos.

Authors:  Sasha A Singh; Allison B Andraski; Hideyuki Higashi; Lang Ho Lee; Ashisha Ramsaroop; Frank M Sacks; Masanori Aikawa
Journal:  JCI Insight       Date:  2021-02-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.